logo
Share SHARE
FONT-SIZE Plus   Neg

Apple Releases Developer Preview Of OS X Mavericks - Quick Facts

Apple Inc. (AAPL) on Monday released a developer preview of OS X Mavericks, the 10th major release of its advanced operating system.

With more than 200 new features, OS X Mavericks brings Maps and iBooks to the Mac, introduces Finder Tags and Tabs, enhances multi-display support for power users, delivers new core technologies for breakthrough power efficiency, and includes an all new version of Safari.

The preview release of OS X Mavericks is available to Mac Developer Program members starting today. Mac users will be able to download Mavericks from the Mac App Store this fall.

"OS X Mavericks is our best version yet and features new Maps and iBooks apps, Finder Tags and Tabs, enhanced multi-display support, performance and energy saving features, and an all new Safari," said Craig Federighi, Apple's senior vice president of Software Engineering.

Additional features in OS X Mavericks include: iCloud Keychain, which safely stores website login information, credit card numbers and Wi-Fi passwords; an updated Calendar, which adds integration with Maps; and interactive Notifications, allowing users to reply to a message, respond to a FaceTime call or even delete an email without leaving the app one is using.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Almost 71 percent of Americans say they don't save enough for their retirement, while around 54 percent believe they will never pay off their debt fully, according to a new national survey. The latest survey, commissioned by Experian together with Get Rich Slowly and other top U.S. personal finance... The biotech space is not for the faint hearted, given the ebbs and flows in terms of the returns from investing in it. However, for one who perseveres and astutely devises strategies with full cognizance of key regulatory events coming up, the probability of drug candidates getting FDA's blessings and sympathy plays in the space, it provides a sea of opportunity and huge upside prospects. Alcobra Ltd.'s Investigational New Drug Applications for drug candidate MDX in Attention Deficit Hyperactivity Disorder and Fragile X Syndrome have been put on full clinical hold, following adverse neurological findings in a pre-clinical study.
comments powered by Disqus
Follow RTT